Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

American Journal of Psychiatry, 2000

1,145 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/9e6cecaba503f53d3c07f84f54183579df86b097

Citations in the corpus

• Deep brain stimulation for treatment-resistant depression. (2005, unknown): “While depression can be effectively treated in the majority of patients by either medication or some form of evidence-based psychotherapy (American Psychiatric Association, 2000), up to 20% of patients fail to respond to standard interventions (Fava, 2003; Keller et al., 1992).”
• Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006, background): “…should be defined solely Neuropsychopharmacology by the nine core criterion depressive symptoms specified in DSM-IV-TR (American Psychiatric Association, 2000a) to define an MDE because these associated symptoms may be a function of other commonly concurrent Axis I, II, or III conditions…”
• Worth the ‘EEfRT’? The Effort Expenditure for Rewards Task as an Objective Measure of Motivation and Anhedonia (2009, background): “Further exploration of anhedonia is particularly important as anhedonic symptoms are less responsive to first-line antide-pressants that act primarily on serotonergic or noradrenergic signaling pathways [6] and often persist after other depressive symptoms are in remission [7].”